PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk shares drop 10% after poor weight loss trial result

Once-a-week injection achieved weight loss of 23%, which is lower than some existing treatments

23 Feb, 10:07 — 23 Feb, 10:07
PostShare

Sources

Showing 1 of 4 sources
FTVery High48d ago

Novo Nordisk shares drop 10% after poor weight loss trial result

Once-a-week injection achieved weight loss of 23%, which is lower than some existing treatments

Read full article →

Coverage Timeline

First report: FT · 23 Feb, 10:07Full coverage: 4 · 2hWindow: 2h
Left-leaningCenterRight-leaning
FT23 Feb, 10:07First to report

Novo Nordisk shares drop 10% after poor weight loss trial result

politiken23 Feb, 10:13

Novo Nordisk-aktie falder efter nye data om vægttabshåb

faz23 Feb, 10:37

Business-Ticker: Novo Nordisk-Aktie fällt um 11 Prozent – Rückschlag mit Abnehmmittel

1h later
naftemporiki23 Feb, 11:50Latest update

Novo Nordisk: Βουτιά 15% για τη μετοχή – Γιατί απογοήτευσε η κλινική δοκιμή του CagriSema

Related Stories

Oil Prices Rise After Previous Day's Sharp Drop

just now

Israeli Ministry of Finance: The war against Iran has cost us 11.5 billion dollars

18m ago

IMF and World Bank Meetings to Focus on Inflation and Growth

23m ago

Clark Medalist Straub: Four tips for better economic policy

31m ago